Anzeige
+++Analysten prognostizierten 13,5 Millionen C$ Umsatz.: Das Unternehmen meldete 20,5 Millionen C$.+++
Portfolio Tracker
Alle Depots an einem Ort. Dein Gesamtvermögen immer im Blick, tiefgründige Renditeanalysen und Dividendenplaner.
Anzeige
EQS-News

BIO-Europe® Celebrates 30th Anniversary with Landmark Event in Stockholm 05.08.2024, 14:00 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: EBD Group / Key word(s): Conference
BIO-Europe® Celebrates 30th Anniversary with Landmark Event in Stockholm

05.08.2024 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


BIO-Europe® Celebrates 30th Anniversary with Landmark Event in Stockholm

Munich, Germany - August 5, 2024 – Join the 30th anniversary edition of BIO-Europe®, the premier biopharma partnering event that has grown with the industry, continually innovating and remaining the hub for impactful conversations and connections. Following a record-breaking 2023, the 2024 event promises even greater opportunities for connection and partnering.

The 30th annual BIO-Europe will be held from November 4–6, 2024, in Stockholm, Sweden. This year's event is set to convene over 5,500 life science professionals from more than 2,800 companies across 60+ countries. Attendees will participate in an impressive 29,000 one-to-one meetings over the three-day event.

For three decades, BIO-Europe has solidified its position as Europe’s flagship partnering event. Its unparalleled international reach attracts participants from every sector of the biotechnology value chain, providing a unique platform to identify, engage, and establish strategic relationships that grow companies and the life sciences industry.

BIO-Europe serves the entire biopharma community, offering startup and innovator programs, insights on industry trends from key opinion leaders, and the gold standard of partnering systems. The event also provides numerous serendipitous networking opportunities, ensuring an exceptional return on investment for all attendees.

EBD Group remains dedicated to offering a global forum for the biopharma community to unite. In support of this commitment, two days of digital partnering will follow the in-person event, ensuring broader accessibility and continued engagement.

One-to-one meetings during the conference will be facilitated by the partneringONE™ platform, ensuring a seamless experience for delegates during both in-person and virtual partnering. The partneringONE platform is the blueprint for best-in-class partnering software, enabling delegates to create connections which turn into successful collaborations. New for this year is partneringONE plus. Fully integrated into the BIO-Europe experience, partneringONE plus is the only solution that allows licensing professionals to find, connect and manage their partnering on a single platform.

Produced by EBD Group, the leading partnering firm for the global biotechnology industry, and supported by the Biotechnology Innovation Organization (BIO), BIO-Europe 2024 is poised to deliver an unparalleled experience for all attendees.

For more information and to register, visit BIO-Europe® 2024.

About EBD Group  

EBD Group’s overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. Today our events (BIO-Europe, BIO-Europe Spring®, Biotech Showcase™, ChinaBio® Partnering Forum, Asia Bio Partnering Forum and BioEquity Europe) annually attract more than 15,000 senior life science executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. EBD Group is an Informa company. For more information, please visit www.ebdgroup.com. 

Media Contacts: 
MC Services AG  
+49 89 2102280  
contact@mc-services.eu  

Karina Marocco 
EBD Group 
kmarocco@ebdgroup.com



05.08.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


1958689  05.08.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1958689&application_name=news&site_id=boersennews_de~~~d41e2cc8-bdcb-47ba-bb51-c77a04513666
Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer